Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn; Servei de Cirurgia Cardiovascular, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn.
J Thorac Cardiovasc Surg. 2015 Jul;150(1):159-67.e1. doi: 10.1016/j.jtcvs.2015.03.044. Epub 2015 Mar 31.
The impact of prior alcohol septal ablation in patients who require septal myectomy for hypertrophic obstructive cardiomyopathy is unknown.
Thirty-one patients with unsuccessful alcohol septal ablation who underwent septal myectomy were matched 1:2 to patients having had a myectomy as the only invasive procedure for hypertrophic obstructive cardiomyopathy. Study outcomes were cardiac death, advanced heart failure, and appropriate implantable cardioverter defibrillator discharge. The results of surgery, echocardiograms, and pathology specimens were compared between groups.
Patients with previous alcohol septal ablation had increased diastolic dysfunction in preoperative echocardiography, as well as more implantable cardioverter defibrillators implanted (32% vs 11%, P = .01), more arrhythmias in preoperative Holter monitoring (43% vs 13%, P = .02), and a higher incidence of postoperative complete heart block (19.4% vs 1.6%, P < .01). Two patients died early postoperatively in the prior alcohol septal ablation group, and no patients died in the primary myectomy group. One patient in each group had an implantable cardioverter defibrillator (P = .52). At a mean follow-up of 3.2 years, 7 of 31 patients and 6 of 62 patients progressed to advanced heart failure in the prior alcohol septal ablation group and the primary myectomy group, respectively (P = .1) Histopathologic analysis demonstrated greater interstitial (70% vs 26%, P < .01) and endocardial fibrosis (87% vs 67%, P = .04) in the alcohol septal ablation group.
Patients with prior alcohol septal ablation undergoing surgical septal myectomy may have an increased risk of cardiac death, advanced heart failure, and implantable cardioverter defibrillator discharges. This supports septal myectomy as the preferred treatment for septal reduction therapy, avoiding scarring and diastolic dysfunction inherent to alcohol septal ablation.
在需要进行室间隔心肌切除术的肥厚型梗阻性心肌病患者中,先前接受酒精室间隔消融术的影响尚不清楚。
31 例酒精室间隔消融术不成功的患者接受了室间隔心肌切除术,与仅接受室间隔心肌切除术治疗肥厚型梗阻性心肌病的患者按 1:2 配对。研究结果为心脏性死亡、晚期心力衰竭和适当的植入式心脏复律除颤器放电。比较两组患者的手术、超声心动图和病理标本结果。
先前接受酒精室间隔消融术的患者术前超声心动图显示舒张功能障碍增加,植入的植入式心脏复律除颤器更多(32%比 11%,P=0.01),术前动态心电图监测的心律失常更多(43%比 13%,P=0.02),术后完全性心脏传导阻滞的发生率更高(19.4%比 1.6%,P<0.01)。在先前接受酒精室间隔消融术的患者中,有 2 例术后早期死亡,而在原发性心肌切除术组中无患者死亡。每组各有 1 例患者植入了植入式心脏复律除颤器(P=0.52)。在平均 3.2 年的随访中,在先前接受酒精室间隔消融术的 31 例患者和原发性心肌切除术的 62 例患者中,分别有 7 例和 6 例进展为晚期心力衰竭(P=0.1)。组织病理学分析显示,酒精室间隔消融术组的间质纤维化(70%比 26%,P<0.01)和心内膜纤维化(87%比 67%,P=0.04)更严重。
先前接受酒精室间隔消融术的患者接受手术室间隔心肌切除术可能会增加心脏性死亡、晚期心力衰竭和植入式心脏复律除颤器放电的风险。这支持室间隔心肌切除术作为室间隔减少治疗的首选治疗方法,避免了酒精室间隔消融术固有的瘢痕和舒张功能障碍。